German call for radical health policy change

18 April 2001

The German Liberal Party, the FDP, has called for a radical change ofdirection in health care policy, calling for the current budgeting of spending on treatment services to be dismantled and replaced by a market-driven system.

In a policy paper prepared by the party's national leadership, the FDP goes on to call for an intensification of competition at all levels of the health service. Insured patients should have the choice between a range of tariffs and offers of treatment, it says, and patients should make a contribution towards the costs of their health care in order to strengthen public awareness of medical expenses.

The report also says that, in order to make cost reimbursement more transparent, health fund patients should receive an account for health services, just as private patients do, which they would then hand in to their respective funds. The FDP also argues that the health funds should not be legally obliged to engage in joint and unified negotiations with health service providers, so that there would be an element of competition to suggest better ideas and produce improvements from the negotiations.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight